afrin
-
Utility of Glucagon-Like-Peptide-1-Receptor Agonists in Mast Cell Activation Syndrome, 2025, Lawrence B. Afrin M.D, Blitsheyn et al
Abstract Introduction: Mast cell (MC) activation syndrome (MCAS) is a collection of illnesses rooted in inappropriate MC activation with little to no neoplastic MC proliferation, distinguishing it from mastocytosis. Due to great heterogeneity in the underlying MC regulatory gene mutational...- Mij
- Thread
- afrin glp-1 mcas svetlana blitshteyn
- Replies: 16
- Forum: Other health news and research
-
Diagnosis of mast cell activation syndrome: a global “consensus-2”, 2020, Afrin et al
Free full text: https://www.degruyter.com/view/journals/dx/ahead-of-print/article-10.1515-dx-2020-0005/article-10.1515-dx-2020-0005.xml- Dolphin
- Thread
- afrin mcas
- Replies: 7
- Forum: Immune: Autoimmune and Mast Cell Disorders